KARACHI: A prominent Pakistani gastroenterologist, Dr. Nazish Butt, represented Pakistan at the prestigious APASL 2026 International Conference held in Istanbul, where she presented on the treatment of acute and chronic Hepatitis E Virus (HEV), highlighting critical clinical and public health concerns.
Dr. Butt, an Associate Professor and Head of the Gastroenterology and Hepatology Department at Jinnah Postgraduate Medical Centre (JPMC), Karachi, was invited as a faculty member at the international forum, reflecting her growing recognition in the global medical community.
During her presentation, she discussed key aspects of HEV, including its genotypes prevalent in Asia and other regions, and emphasized the serious risks associated with acute infection during pregnancy, where mortality rates can range between 15 to 25 percent. She also highlighted the challenges of chronic Hepatitis E, particularly in immunocompromised individuals, including HIV-positive patients and organ transplant recipients.
Dr. Butt underscored the importance of timely diagnosis, recommending that HEV testing be included in patients with elevated liver enzymes, especially in high-risk groups. She further noted that prolonged infection can lead to severe complications such as liver cirrhosis and hepatic failure, advocating for early treatment interventions including the use of antiviral therapy where appropriate.
A consultant gastroenterologist with MBBS and FCPS qualifications, Dr. Butt has extensive experience in hepatology and digestive diseases, with affiliations to leading institutions including Aga Khan University Hospital and National Medical Centre.
Her participation at APASL 2026 not only highlights Pakistan’s contribution to global hepatology research but also reinforces the need for increased awareness and preventive strategies against viral hepatitis.
Medical experts say such international engagements are crucial for knowledge exchange and improving patient care standards in Pakistan, particularly in the field of liver diseases where the burden remains significant.
Dr. Butt concluded her message by emphasizing that prevention remains the most effective strategy against Hepatitis E and other liver diseases.
